Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation - Benzinga Get link Facebook X Pinterest Email Other Apps March 31, 2020 Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation Benzinga Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment